Friday, December 9

Tag: cancer

Aerosol products at higher risk for benzene, says scientist who spurred recalls
Business

Aerosol products at higher risk for benzene, says scientist who spurred recalls

Unilever is recalling dry shampoo aerosol products sold nationwide because they may contain elevated levels of benzene, a human carcinogen. The recall is the latest of half a dozen so far this year, with the cancer-causing chemical showing up in products including deodorant, hand sanitizer and sunscreen.People should take the benzene-related recalls seriously, as they involve a far more dangerous contaminant than most, according to David Light, CEO of Valisure, an independent lab in New Haven, Connecticut, that alerted the Food and Drug Administration to its findings of benzene in sunscreen sprays last year. "Benzene is such a bad molecule — it's at the very top of the FDA's list of 70-some solvents not to use," Light told CBS MoneyWatch, adding that unlike with some chemicals, "th...
AAPHC using new technology to determine skin cancer
Science

AAPHC using new technology to determine skin cancer

ALBANY, Ga. (WALB) - Albany Area Primary Health Care is using technology to determine if someone may have skin cancer. They’re doing this at their medical center in Lee County. They’re using this new technology to give patients some answers, but also to lower the number of patients dermatologists see.According to the CDC, melanoma is the most deadly type of skin cancer, and it’s also the most common form of cancer in the U.S.Catching skin cancer at its earliest stage is important for treatment. To help with that, Dr. Sam Waling, a physician at Albany Area Primary Health Care, is using dermoscopy.It’s essentially a microscope attached to an iPhone. Waling holds the camera to a spot on a person’s arm, and a few seconds later, he has a digital scan. Using that scan, he can send it to a dermat...
What do retail and pharmacy have in common? How RFID technology can serve as part of a comprehensive solution to diversion
Science

What do retail and pharmacy have in common? How RFID technology can serve as part of a comprehensive solution to diversion

Retail and pharmacy – two very different industries that, on the surface, might not appear to have much in common. However, the two fields have found a use for an emerging technology to solve very similar problems. Radio frequency identification (RFID) technology is an incredibly valuable resource that has been introduced in the retail space to track inventory and detect and deter theft. Now, RFID is bringing immense value to the healthcare space,continuing to show promise and results, especially when incorporated into a comprehensive drug diversion prevention program. RFID technology uses wireless communication and radio waves to identify and track items and equipment. RFID tags can store a significant amount of data, whether it be a single serial number or several pages of material. Wi...
Technoblade, popular internet gamer, dies at 23 after battle with cancer
Entertainment

Technoblade, popular internet gamer, dies at 23 after battle with cancer

The popular Minecraft YouTuber known as Technoblade has died after a battle with stage four cancer, his family announced. He was 23. In an emotional video titled "so long losers" posted on Technoblade's YouTube account, the internet gamer's father read a message written by his late son.  Internet gamer Technoblade has died after a battle with stage four cancer Technoblade via YouTube "Thank you all for supporting my content over the years," the message read. "If I had another 100 lives, I think I would choose to be Technoblade again every single time as those were the happiest years of my life. I hope you guys enjoyed my content and that I made some you laugh and I hope you al...
The new paradigm in drug development: Why platform technology is the solution patients and payers need
Science

The new paradigm in drug development: Why platform technology is the solution patients and payers need

We are living in a dynamic time of drug development and innovation with many beneficiaries—the most important being the patient. These developments include everything from exciting gene therapies for rare diseases to mRNA technology that allowed the development of the COVID vaccine in record time. Yet we are facing significant challenges as well. There is a global call for more equitable pricing and broader access—especially for the newer innovative treatments. How can we as healthcare leaders answer that call? How can we work with our stakeholders to ensure that the system can effectively support new innovations so that the most important stakeholder—the patient—will benefit? Collaboration and partnerships In answering the call, we must focus our attention on where it has the most impa...